Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 10516691 | HLA-A (HLA-A) | stem cell transplantation | NA | NA | NA | unclassified | |
| three different types of anti-t cell antibody were used in patients undergoing haematopoietic stem cell transplantation (hsct) with an hla-a, -b and -dr compatible unrelated donor: atg-fresenius (atg-f) (n = 26), thymoglobuline (tmg) (n = 61) and okt-3 (n = 45). | |||||||
| 10516691 | HLA-DR (HLA-DR) | stem cell transplantation | NA | NA | NA | unclassified | |
| three different types of anti-t cell antibody were used in patients undergoing haematopoietic stem cell transplantation (hsct) with an hla-a, -b and -dr compatible unrelated donor: atg-fresenius (atg-f) (n = 26), thymoglobuline (tmg) (n = 61) and okt-3 (n = 45). | |||||||
| 10546788 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| this has allowed a better assessment of the degree of matching of donor and recipient, which has reiterated the pivotal importance of hla compatibility for the outcome of a stem cell transplantation. | |||||||
| 10713622 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | negation | |
| patients requiring allogeneic stem cell transplantation who do not have an hla-matched related donor can sometimes obtain an unrelated donor by searching volunteer registries. | |||||||
| 10942932 | HLA MISMATCHED (HLA-MISMATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| follow-up of chimerism status after allogeneic hla-mismatched stem cell transplantation by detection of non-shared hla alleles. | |||||||
| 10942932 | HLA MISMATCHED (HLA-MISMATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| here, we report an alternative method for following the chimerism status after an hla-mismatched stem cell transplantation (sct), detecting the presence of non-shared hla alleles by reference-strand mediated conformation analysis (rsca).design and we tested this new approach on allogeneic related haploidentical sct, unrelated cord blood transplantation, and hla-mismatched unrelated donor sct. | |||||||
| 10965369 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
| both patients were treated by stem cell transplantation, the one with a matched unrelated donor, the second with stem cells from her hla-identical sister. | |||||||
| 11000992 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
| in chronic myeloid leukaemia (cml) allogeneic stem cell transplantation can be proposed to a minority of patients who are both less than 50 years of age and have an hla-identical donor. | |||||||
| 11019837 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
| a low cd34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from hla-identical siblings: should 2 x 10(6) cd34+ cells/kg be considered the minimum threshold? | |||||||
| 11244433 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
| in order to improve the outcome, we employed allogeneic stem cell transplantation (allo-sct) for atl in 10 patients, nine of whom were from hla-identical siblings and one from an unrelated donor. | |||||||
Copyright 2024